Sharechat Logo

GEN - Extraordinary Shareholders Meeting and Director Nominations

Friday 2nd December 2022

Text too small?

General Capital Limited announces that it is expecting to hold an Extraordinary Meeting of Shareholders in mid-January to vote on the placement of new shares and possible additional Directors. Further details of the location, time, resolutions and voting processes for the annual meeting will be set out in the Notice of Meeting to be sent to shareholders in due course.

 

For the purposes of NZX Listing Rule 2.3.2, General Capital also advises that the closing date for Director nominations is Monday, 19 December 2022.

 

Nominations may only be made by a shareholder entitled to attend and vote at the annual meeting and must be received by General Capital by 5:00pm (NZT) on the closing date.

 

The nominating shareholder should provide (at the time of nomination or as soon as possible thereafter and prior to closing date for nominations) sufficient information to enable the directors of the company to undertake the due diligence process to ascertain the candidate’s character, experience, education, criminal record, and bankruptcy history in accordance with clause 4.1 of the Company’s Procedure for Nomination and Appointment of Directors. A copy of the Board Policies and Procedures is available on the Company’s website.

 

Nominations can be sent by email to victor.pliev@gencap.co.nz or by mail to:

 

Chief Financial Officer

General Capital Limited

PO Box 1314

Shortland Street

Auckland 1010

 

For further information contact:

 

Brent King

Managing Director

General Capital Limited

+64 21 632 660

Brent.King@gencap.co.nz

 

2 December 2022

 

END



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b